Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
228
-
Total 13F shares, excl. options
-
95.5M
-
Shares change
-
-2.14M
-
Total reported value, excl. options
-
$3.71B
-
Value change
-
-$96.8M
-
Put/Call ratio
-
0.9
-
Number of buys
-
119
-
Number of sells
-
-109
-
Price
-
$38.79
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q2 2021
294 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q2 2021.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 228 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.5M shares
of 157M outstanding shares and own 60.73% of the company stock.
Largest 10 shareholders include FMR LLC (18.7M shares), VANGUARD GROUP INC (11.7M shares), BlackRock Inc. (8.35M shares), WELLINGTON MANAGEMENT GROUP LLP (4.25M shares), Capital World Investors (4.17M shares), ALKEON CAPITAL MANAGEMENT LLC (4.08M shares), STATE STREET CORP (3.61M shares), RA CAPITAL MANAGEMENT, L.P. (3.34M shares), LORD, ABBETT & CO. LLC (2.83M shares), and MAVERICK CAPITAL LTD (2.82M shares).
This table shows the top 228 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.